Phase IV study evaluating effectiveness and safety of talazoparib in patients with locally advanced or metastatic HER2 negative breast cancer and a BRCA1 or BRCA2 mutation (ViTAL)

Delphine Loirat, Marie Duboys de labarre, Christine Essner, Ioana Hrab,Jean-Christophe Thery,Christelle Jouannaud,Perrine Vuagnat,Pauline Soibinet-Oudot, Anne Creisson,Audrey Mailliez, Jean-Loup Mouysset, Laura Salabert,Nadine Dohollou,Jean-David Fumet,Thibault De La Motte Rouge, Jean-Michel Vauthier, Maylis Decrop,Pascal Pujol

CANCER RESEARCH(2022)

引用 1|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要